PresentationBioStock: interview with Helén Tuvesson: Active Biotech kommenterar första doseringen i uppdaterad myelofibrosstudie (in Swedish)
PresentationRedeye: Active Biotech (Intervju): Redeye pratar med vd Helén Tuvesson om nuläget (in Swedish)
PresentationRedeye: Active Biotech (Intervju): Redeye pratar med vd Helén Tuvesson om nyemissionen (in Swedish)
PresentationThe LION Study: Safety, Tolerability and Distribution of Topical Laquinimod Eye Drops, an Innovative Immunomodulator Targeting Aryl Hydrocarbon Receptor
PresentationRedeye: Active Biotech: Presenation and interview with CMO Erik Vahtola and Stanford Medicine researchers
PresentationSafety, Tolerability, and Distribution of Topical Laquinimod Eye Drops: Primary Outcomes of the Lion Study
